Abiomed Profit Margin

As of the most recent data (September 2022), ABMD shows a profit margin of 24.84%. That compares with 15.32% in the prior-year period — up 62.1% year over year. That is above the Healthcare sector average of 13.76%. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ABMD's profit margin is now 24.84% (was 15.32%) — a 62.1% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Abiomed is outperforming or lagging.

The Healthcare sector average profit margin is about 13.76%. Abiomed is at 24.84%, which is higher that average. That is roughly 80.5% above the sector mean. Use the comparison chart on this page to see how ABMD stacks up against individual peers as well.

That compares with 15.32% in the prior-year period — up 62.1% year over year. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Abiomed with peers to see if the move is company-specific or sector-wide.

Besides this profit margin page, Stockcircle has Abiomed's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect profit margin (currently 24.84%) with ownership activity and broader fundamentals.